Search Results

3 results

  1. TSRC, Tob. Sci. Res. Conf., 2017, 71, abstr. 068

    The scientific evidence for the proposed NNN standard

    MARANO K.M.(1); LIU C.(1); CURTIN G.M.(1); PARMS T.(1); BACHAND A.(2); SULSKY S.I.(2); MARIANO G.(2); GREENE T.(3); GENTRY P.R.(3)
    (1) RAI Services Company, Winston-Salem, NC; USA; (2) Ramboll Environ, Amherst, MA, USA; (3) Ramboll Environ, Monroe, LA, USA
    The US Food and Drug Administration (FDA) published a proposed standard of 1 µg/g (dry weight) N-nitrosonornicotine (NNN) in finished smokeless tobacco (ST) products. FDA’s rationale for the standard is that NNN is a potent carcinogen, NNN is a major ...
  2. TSRC, Tob. Sci. Res. Conf., 2017, 71, abstr. 110

    Modeling the population health effects of Camel snus with reduced risk information

    BACHAND A.(1); SULSKY S.I.(1); SHIFFMAN S.(2); CURTIN G.M.(3)
    (1) Ramboll Environ U.S., Amherst, MA, USA; (2) Pinney Associates, Pittsburgh, PA, USA; (3) RAI Services Company, Winston-Salem, NC, USA
    We present findings from a statistical model, used to assess the population health effects of Camel Snus with reduced risk information. Analyses followed a single cohort of 1 million males from age 13 to age 72, comparing the number of survivors in a base ...